Kirsten Grønbæk

Kirsten Grønbæk

Clinical Professor

Member of:

  • Internal Medicine: Haematology


  1. 2014
  2. Published

    A novel del(8)(q23.2q24.11) contributing to disease progression in a case of JAK2/TET2 double mutated chronic myelomonocytic leukemia

    Toft-Petersen, M., Kjeldsen, E., Nederby, L., Grønbæk, Kirsten, Hokland, P. & Roug, A. S., 2014, In: Leukemia Research Reports. 3, 2, p. 94-97 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma

    Kristensen, L. S., Asmar, F., Dimopoulos, K., Nygaard, M. K., Aslan, D., Hansen, Jakob Werner, Ralfkiaer, E. & Grønbæk, Kirsten, 2014, In: OncoTarget. 5, 20, p. 9798-810 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial

    Holm, M., Dybedahl, I., Holm, M., Karimi, M., Brandefors, L., Garelius, H., Grövdal, M., Dufva, I. H., Grønbæk, Kirsten, Jansson, M., Marcher, C., Nilsson, L., Kittang, A. O., Porwit, A., Saft, L., Möllgård, L. & Hellström-Lindberg, E., 2014, In: Pediatric Blood & Cancer. 4, 3, p. 1-7 7 p., e189.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

    Kolstad, A., Laurell, A., Jerkeman, M., Grønbæk, K., Elonen, E., Räty, R., Pedersen, L. B., Loft, A., Bogsrud, T. V., Kimby, E., Hansen, P. B., Fagerli, U-M., Nilsson-Ehle, H., Lauritzsen, G. F., Lehmann, A. K., Sundstrom, C., Karjalainen-Lindsberg, M-L., Ralfkiaer, E., Ehinger, M., Delabie, J. & 7 others, Bentzen, H., Schildt, J., Kostova-Aherdan, K., Frederiksen, H., Brown, P. D. N., Geisler, C. H. & Nordic Lymphoma Group, N. L. G., 2014, In: Blood. 123, 19, p. 2953 - 2959 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Paraneoplastisk pancytopeni hos en patient med uerkendt lungecancer

    Hansen, J. W., Sjö, L. & Grønbæk, Kirsten, 2014, In: Ugeskrift for Laeger. 176, 19, p. 2-3 2 p., V11130675.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    The role of epigenetics in the biology of multiple myeloma

    Dimopoulos, K., Gimsing, P. & Grønbæk, Kirsten, 2014, In: Blood Cancer Journal. 4, 5, p. 1-10 10 p., e207.

    Research output: Contribution to journalReviewResearchpeer-review

  8. Published

    Validation of a diagnostic miRNA classifier in cutaneous T-cell lymphomas

    Marstrand, T., Ahler, C. B., Ralfkiaer, U., Clemmensen, A., Kopp, K. L., Sibbesen, N. A., Krejsgaard, T., Litman, Thomas, Wasik, M. A., Bonefeld, Charlotte Menne, Grønbæk, Kirsten, Gjerdum, L. M. R., Gniadecki, R., Ralfkiaer, E., Geisler, Carsten, Woetmann, Anders , Røpke, M. A., Glue, C., Skov, Lone & Ødum, Niels, 2014, In: Leukemia and Lymphoma. 55, 4, p. 957-958 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Predicting response to epigenetic therapy

    Treppendahl, M. B., Sommer Kristensen, L. & Grønbæk, Kirsten, Jan 2014, In: The Journal of Clinical Investigation. 124, 1, p. 47-55 9 p.

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another “double hit” lymphoma with very poor outcome?

    Asmar, F., Hother, C., Kulosman, G., Treppendahl, M. B., Nielsen, H. M., Ralfkiaer, U., Pedersen, A., Møller, M. B., Ralfkiaer, E., de Nully Brown, P. & Grønbæk, Kirsten, 15 Apr 2014, In: OncoTarget. 5, 7, p. 1912-25 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat

    Andersen, C. L., Bjørn, M. E., McMullin, M. F., Harrison, C., Samuelsson, J., Ejerblad, E., Zweegman, S., Fernandes, S., Bareford, D., Knapper, S., Löfvenberg, E., Linder, O., Andreasson, B., Ahlstrand, E., Jensen, M. K., Bjerrum, O. W., Vestergaard, H., Larsen, H., Klausen, T. W., Mourits-Andersen, T. & 5 others, Skov, V., Thomassen, M., Kruse, T., Grønbæk, Kirsten & Hasselbalch, H. C., Jul 2014, In: Leukemia Research. 38, 7, p. 816-821 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...17 Next

ID: 37722667